Trial · NCT07910877
Trigger Point Injection and Myofascial Release for Cervicogenic Headache
NCT07910877, Not applicable, Not yet recruiting, Konya Beyhekim Training and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Trigger Point Injection and Myofascial Release for Cervicogenic Headache. Trials, record NCT07910877. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910877
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Trigger Point Injection and Myofascial Release for Cervicogenic Headache
- NCT number
- NCT07910877
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Konya Beyhekim Training and Research Hospital
- Conditions
- Cervicogenic Headache
- Interventions
- Trigger Point Injection + Home Exercise, Experimental: Myofascial Release + Home Exercise, Combined Trigger Point Injection and Myofascial Release, Home Exercise Program
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Pain Intensity on the Visual Analog Scale (VAS) | Baseline, Week 4 (end of treatment), and Week 8 (1 month after treatment) | Change in headache pain intensity from baseline to the end of the 4-week treatment period, measured using the Visual Analog Scale (VAS). The change will be compared among the four study groups. |
| Secondary | Change in Headache-Related Disability Index (HDI) Score | Baseline, Week 4, and Week 8 | Change in headache-related disability measured using the Headache Disability Index (HDI). Scores will be assessed at baseline, at the end of treatment, and one month after treatment completion. |
| Secondary | Change in Headache Impact Test (HIT-6) Score | Baseline, Week 4, and Week 8 | Change in the impact of headache on daily functioning measured using the Headache Impact Test (HIT-6). Scores will be assessed at baseline, at the end of treatment, and one month after treatment completion. |
| Secondary | Change in 12-Item Short Form Health Survey (SF-12) Score | Baseline, Week 4, and Week 8 | Change in health-related quality of life measured using the 12-Item Short Form Health Survey (SF-12). Scores will be assessed at baseline, at the end of treatment, and one month after treatment completion. |
| Secondary | Change in Number of Headache Days per Week | Baseline, Week 4, and Week 8 | Change in the number of days with headache during the preceding 7 days, recorded in a headache diary. Headache days will be assessed at baseline, at the end of treatment, and one month after treatment completion. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910877
GET https://conductscience.org/api/trials/v1/NCT07910877/registered